skip navigationU S P T O SealUnited States Patent and Trademark Office AOTW logo
Home|Site Index|Search|Guides|Contacts|eBusiness|eBiz alerts|News|Help
Assignments on the Web > Patent Query
Patent Assignment Abstract of Title
NOTE:Results display only for issued patents and published applications. For pending or abandoned applications please consult USPTO staff.

Total Assignments: 7
Patent #:
8003673
Issue Dt:
08/23/2011
Application #:
11916089
Filing Dt:
11/30/2007
Publication #:
20090298750
Pub Dt:
12/03/2009
Inventors:
Jeffrey Alder, Jared Silverman, Lawrence Mortin, Andrew Van Praagh
Title:
DAPTOMYCIN FOR THE TREATMENT OF BIOFILM AND CATHETER SALVAGE
Assignment: 1
Reel/Frame:
020247/0056Recorded: 12/07/2007Pages: 6
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
MORTIN, LAWRENCE I.
Exec Dt:
06/24/2005
VANPRAAGH, ANDREW
Exec Dt:
06/24/2005
ALDER, JEFFREY
Exec Dt:
06/28/2005
SILVERMAN, JARED
Exec Dt:
06/24/2005
Assignee:
CUBIST PHARMACEUTICALS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
Correspondent:
CUBIST PHARMACEUTICALS, INC.
65 HAYDEN AVENUE
LEXINGTON, MA 02421
Assignment: 2
Reel/Frame:
019801/0166Recorded: 09/10/2007Pages: 5
Conveyance:
ASSIGNMENT OF ASSIGNORS INTEREST (SEE DOCUMENT FOR DETAILS).
Assignors:
ALDER, JEFFREY
Exec Dt:
04/03/2007
SILVERMAN, JARED
Exec Dt:
04/04/2007
MORTIN, LAWRENCE
Exec Dt:
04/03/2007
VAN PRAAGH, ANDREW
Exec Dt:
04/06/2007
Assignee:
CUBIST PHARMACEUTICALS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
Correspondent:
CUBIST PHARMACETUICALS, INC.
65 HAYDEN AVENUE
WILLIAM D. DEVAUL
LEXINGTON, MA 02421
Assignment: 3
Reel/Frame:
029339/0669Recorded: 11/20/2012Pages: 23
Conveyance:
SECURITY AGREEMENT
Assignors:
CUBIST PHARMACEUTICALS, INC.
Exec Dt:
11/20/2012
ADOLOR CORPORATION
Exec Dt:
11/20/2012
CALIXA THERAPEUTICS, INC.
Exec Dt:
11/20/2012
CUBIST PHARMACEUTICALS HOLDINGS, INC.
Exec Dt:
11/20/2012
CUBIST PHARMACEUTICALS U.S.
Exec Dt:
11/20/2012
Assignee:
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
20 KING STREET WEST, 4TH FLOOR
TORONTO, ONTARIO, CANADA M5H1C4
Correspondent:
ROBIN RILEY
75 EAST 55TH STREET
NEW YORK, NY 10022
Assignment: 4
Reel/Frame:
036283/0189Recorded: 08/05/2015Pages: 7
Conveyance:
CHANGE OF NAME (SEE DOCUMENT FOR DETAILS).
Assignor:
CUBIST PHARMACEUTICALS, INC.
Exec Dt:
06/29/2015
Assignee:
CUBIST PHARMACEUTICALS LLC
2000 GALLOPING HILL ROAD
KENILWORTH, NEW JERSEY 07033
Correspondent:
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
Assignment: 5
Reel/Frame:
036308/0207Recorded: 08/12/2015Pages: 13
Conveyance:
SECURITY INTEREST (SEE DOCUMENT FOR DETAILS).
Assignor:
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Exec Dt:
07/07/2015
Assignees:
CUBIST PHARMACEUTICALS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
ADOLOR CORPORATION
700 PENNSYLVANIA DRIVE
EXTON, PENNSYLVANIA 19341
CALIXA THERAPEUTICS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
Correspondent:
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
Assignment: 6
Reel/Frame:
036355/0184Recorded: 08/14/2015Pages: 14
Conveyance:
CORRECTIVE ASSIGNMENT TO CORRECT THE NATURE OF CONVEYANCE PREVIOUSLY RECORDED AT REEL: 036308 FRAME: 0207. ASSIGNOR(S) HEREBY CONFIRMS THE RELEASE OF SECURITY INTEREST.
Assignor:
ROYAL BANK OF CANADA, AS ADMINISTRATIVE AGENT
Exec Dt:
07/07/2015
Assignees:
CUBIST PHARMACEUTICALS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
ADOLOR CORPORATION
700 PENNSYLVANIA DRIVE
EXTON, PENNSYLVANIA 19341
CALIXA THERAPEUTICS, INC.
65 HAYDEN AVENUE
LEXINGTON, MASSACHUSETTS 02421
Correspondent:
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018
Assignment: 7
Reel/Frame:
040026/0743Recorded: 09/14/2016Pages: 3
Conveyance:
CHANGE OF ADDRESS
Assignor:
CUBIST PHARMACEUTICALS LLC
Exec Dt:
07/14/2016
Assignee:
CUBIST PHARMACEUTICALS LLC
WEYSTRASSE 20
6000 LUCERNE 6, SWITZERLAND
Correspondent:
LADAS & PARRY LLP
1040 AVENUE OF THE AMERICAS
NEW YORK, NY 10018

Search Results as of: 05/10/2024 01:34 AM
If you have any comments or questions concerning the data displayed, contact PRD / Assignments at 571-272-3350. v.2.6
Web interface last modified: August 25, 2017 v.2.6
| .HOME | INDEX| SEARCH | eBUSINESS | CONTACT US | PRIVACY STATEMENT